Opsens Inc. to Post FY2021 Earnings of $0.07 Per Share, M Partners Forecasts (TSE:OPS) – Riverton Roll

Posted: Published on January 22nd, 2020

This post was added by Alex Diaz-Granados

Opsens Inc. (TSE:OPS) Equities research analysts at M Partners upped their FY2021 earnings estimates for Opsens in a report released on Tuesday, January 14th, according to Zacks Investment Research. M Partners analyst A. Hood now expects that the company will post earnings per share of $0.07 for the year, up from their previous estimate of $0.05.

Opsens (TSE:OPS) last posted its quarterly earnings results on Thursday, November 14th. The company reported C($0.02) earnings per share for the quarter. The firm had revenue of C$7.87 million for the quarter.

TSE:OPS opened at C$0.88 on Wednesday. The companys 50-day moving average price is C$0.86 and its 200-day moving average price is C$0.87. The company has a current ratio of 4.92, a quick ratio of 3.70 and a debt-to-equity ratio of 85.14. The company has a market cap of $76.74 million and a P/E ratio of -16.00. Opsens has a twelve month low of C$0.73 and a twelve month high of C$1.05.

About Opsens

Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates through two segments, Medical and Industrial. It primarily focuses on the measure of FFR in interventional cardiology.

Featured Story: Trading Penny Stocks

Get a free copy of the Zacks research report on Opsens (OPS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.

See the original post:
Opsens Inc. to Post FY2021 Earnings of $0.07 Per Share, M Partners Forecasts (TSE:OPS) - Riverton Roll

Related Posts
This entry was posted in Interventional Cardiology. Bookmark the permalink.

Comments are closed.